|Bid||98.23 x 1200|
|Ask||98.61 x 800|
|Day's Range||97.68 - 98.66|
|52 Week Range||63.59 - 102.23|
|Beta (5Y Monthly)||0.60|
|PE Ratio (TTM)||29.97|
|Earnings Date||Nov 03, 2021 - Nov 08, 2021|
|Forward Dividend & Yield||0.56 (0.62%)|
|Ex-Dividend Date||Jun 10, 2021|
|1y Target Est||111.80|
The U.S. Centers for Disease Control and Prevention (CDC) recently awarded global consulting and digital services provider ICF (NASDAQ:ICFI) a $31 million recompete contract to provide development, operations and maintenance support to the agency's nationwide syndromic surveillance platform, BioSense. The contract has a term of four years, including a one-year base and three one-year options.
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Is ICF International (ICFI) a great pick from the value investor's perspective right now? Read on to know more.